Can you get medical cannabis free on the NHS? Who does, how the pathway works, and what “free” means at a private clinic

The numbers, with their sources

Figures are for England because the NHS Business Services Authority processes English prescriptions; Scotland, Wales and Northern Ireland publish separately and the same NICE guideline applies in Wales and Northern Ireland. Checked 9 October 2026. How we verify.

How the NHS pathway works

Since 1 November 2018 cannabis-based products for medicinal use have been Schedule 2 medicines that only a doctor on the GMC Specialist Register may initiate; a GP cannot start one, on the NHS or privately, though a GP may continue a specialist's prescription under a shared-care arrangement. On the NHS the specialist needs two things that a private clinic does not: a reason that fits NICE guidance, and funding. For the three licensed medicines within their NICE indications, funding follows the guideline — this is where the 880 patients come from. For anything unlicensed, or anything licensed but outside its indication, the specialist must apply to their own trust or integrated care board through an Individual Funding Request, show that licensed alternatives have been tried or are unsuitable, and carry personal responsibility for prescribing an unlicensed medicine. Most applications fail; the ones that succeed are counted in single figures nationally.

What this means in practice: if you have severe treatment-resistant epilepsy of the two named syndromes, MS spasticity that has not responded to other treatment, or chemotherapy-induced nausea that standard anti-emetics do not control, ask your specialist about the NICE route — it is a normal NHS prescription, free at the point of use apart from the standard prescription charge in England (free in Scotland, Wales and Northern Ireland). If your condition is chronic pain, anxiety or anything else, the NHS route exists on paper and is closed in practice; the private route is what the 1.7 million items represent.

What “free” means at a private clinic

A private prescription carries no NHS subsidy: you pay the clinic's fees and the pharmacy's price for the medicine. Clinics compete on the first part. Of the 26 CQC/HIW-registered clinics on this site, one publishes consultations at no charge at all (Emerald Health Clinic), and two others currently advertise a £0 first appointment as a promotion against a published list price (Dispensed, list £19; Integro Clinics, list £95). A £0 consultation is a real saving — but the first year of clinic fees across all clinics that publish prices runs from £0 to £900 (median £186), and the medicine typically costs far more than the clinic over a year. What a first year of clinic fees adds up to, clinic by clinic · what is dispensed and at what published price.

Two things to know before taking a free consultation at face value. First, UK clinics may not advertise prescription-only medicines to the public, and the Advertising Standards Authority ruled in January 2026 against one clinic's “cheapest in the UK” claim for omitting fees and eligibility conditions (ruling A25-1312203) — a £0 headline deserves the same reading: what is the follow-up price, what is the per-prescription fee, who qualifies. Second, some clinics run access plans at reduced rates for defined groups (veterans, low income, transfers from another clinic); they are published on the clinic's card where the clinic publishes them, and they are excluded from the first-year figure precisely because eligibility is restricted.

What might change

The Advisory Council on the Misuse of Drugs was commissioned in 2025 to review the 2018 rescheduling, with a report expected from late summer 2026; its November 2020 review recommended a patient registry that captured around 1,000 NHS patients and none of the private ones. Patient groups published a white paper in August 2026 asking for an NHS pilot and an updated NICE review. None of that changes the pathway today; when it does, the table above changes with it, with a date.